In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued 24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the content. The complete, corrected release follows:
CART BP Redefines Blood Pressure Monitoring with Clinically Proven Cuffless Technology
SEOUL, South Korea, Nov. 21, 2024 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea, developed CART BP—the world's first ring-shaped, cuffless device designed for 24-hour blood pressure monitoring. Unlike conventional smartwatches, CART BP delivers more stable photoplethysmography (PPG) signals, ensuring highly accurate blood flow measurements through the finger. Wrist-based devices often struggle with accuracy due to variations in wrist size and sensor positioning. In contrast, CART BP offers multiple ring sizes for a customized fit, significantly improving measurement precision. Its accuracy has been rigorously validated in clinical trials.
One of CART BP's most significant advantages is its ability to provide continuous, cuffless blood pressure monitoring, offering greater convenience compared to traditional devices. CART BP ensures constant, unobtrusive monitoring, delivering valuable data throughout both day and night—making it an ideal tool for effective hypertension monitoring.
The ISH position paper has been endorsed by leading organizations including the World Hypertension League (WHL), the European Society of Hypertension (ESH), the Asian Pacific Society of Hypertension (APSH) and the Latin American Society of Hypertension (LASH).
According to the ISH Position Paper, "A clinical study published in 2024 indicated that the device showed good agreement with ISO requirements and strong correlation with conventional ABPM devices for daytime and nighttime BP measurements. However, calibration of the ring using cuff BP measurement was performed immediately before the accuracy testing component, and the testing was not performed in accordance with recent ESH recommendations developed specifically for cuffless devices."
Sky Labs remains committed to advancing wearable health technology, continually improving the accuracy and accessibility of blood pressure monitoring. This recognition from the ISH further solidifies CART BP's position as a leading solution in hypertension care, setting new benchmarks in patient monitoring and healthcare innovation.
About Sky Labs
Founded in September 2015, Sky Labs is a leading healthcare startup that has developed CART (Cardio Tracker), a ring-shaped medical device designed for disease monitoring using heart signals collected through optical sensors. Following this, the company developed CART BP, a cuffless, ring-shaped device that enables continuous 24-hour blood pressure monitoring, providing valuable treatment information and making a groundbreaking contribution to improving the quality of life for hypertension patients. Sky Labs has signed an exclusive domestic distribution agreement for CART BP with South Korea's Daewoong Pharmaceutical and is preparing for nationwide sales to hospitals, clinics, and general consumers.
Media Inquiries
Edelman Korea SkyLabs@edelman.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
/C O R R E C T I O N -- Sky Labs/
Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension
LAS VEGAS, Jan. 17, 2026 /PRNewswire/ -- At CES 2026, Flowtica was not the loudest presence on the show floor. Over the course of the week, however, the Singapore-based AI company became one of the most closely watched, drawing sustained attention from media, investors, and industry observers.
That attention has now translated into availability. Following its appearance as a CES 2026 Innovation Award Honoree, Flowtica has officially opened sales of Flowtica Scribe, its AI recording pen that quietly stood out in a field dominated by phone-dependent and screen-heavy solutions.
Flowtica Scribe did not make its first public appearance at CES. The product launched on Kickstarter several months earlier, where it attracted thousands of users and established early validation. CES marked a different stage for the company. The focus shifted away from introduction and toward closer examination, with many observers asking whether the idea could hold up beyond early enthusiasm.
Throughout the exhibition, Flowtica's booth at Eureka Park became a steady meeting point for investors and journalists. Conversations rarely centered on specifications or feature lists. Instead, discussions focused on a more fundamental question: whether AI recording tools are beginning to converge on forms that genuinely fit into professional life.
Flowtica's answer was visible in its choice of form. By embedding AI into a pen, an object already accepted in boardrooms, consultations, investor meetings, and sales conversations, the company avoided many of the social and practical frictions that continue to limit phone-based recorders. The result was a device that felt less like a new category of gadget and more like a natural extension of existing behavior.
This restraint is deliberate. Flowtica Scribe is designed to remain unobtrusive, with no screen and no demand for user attention during conversations. Recording, organization, and interpretation take place quietly in the background, allowing users to remain focused on the discussion itself. Among on-site observers, this approach positioned Flowtica as one of the more pragmatic entrants in an increasingly crowded AI recording market.
Hardware, however, represents only part of Flowtica's differentiation. The company places equal emphasis on what happens after recording ends. Its AI functions as a continuously evolving insight system that can operate autonomously while remaining responsive to clear user guidance when needed. Over time, it adapts to individual working rhythms and priorities, shifting the emphasis from capturing everything to identifying what truly matters.
Rather than simply storing conversations, Flowtica helps determine which moments should be retained, revisited, and translated into next actions. Key insights are designed to integrate naturally with existing productivity tools, including calendars and task systems, allowing them to fit into established workflows rather than compete with them.
As interest in Flowtica Scribe built during CES, one question surfaced repeatedly. When would the product be available beyond the show floor?
With sales now officially open through Flowtica's website, the company moves from exhibition attention to real-world deployment. For Flowtica, this moment appears less like a conclusion and more like a transition, from being observed to being used.
As the AI recording market continues to mature, competition is shifting away from novelty and early adoption toward durability. The defining question is no longer whether a system can record conversations, but whether it can remain useful over time.
Flowtica enters this next phase with an approach that is measured and quietly confident, placing its bet not on spectacle, but on long-term relevance.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
The AI Recording Pen That Turned Heads at CES Is Finally for Sale
